Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
1.960
-0.150 (-7.11%)
At close: Jun 5, 2026, 4:00 PM EDT
1.940
-0.020 (-1.02%)
After-hours: Jun 5, 2026, 7:38 PM EDT
CDIO Market Cap
CDIO has a market cap or net worth of $5.8 million as of June 5, 2026. Its market cap has decreased by -22.95% in one year.
Market Cap
5.80M
Enterprise Value
-743.46K
1-Year Change
-22.95%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since July 26, 2022, CDIO's market cap has decreased from $368.96M to $5.80M, a decrease of -98.43%. That is a compound annual growth rate of -65.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 5.80M | 17.22% |
| Dec 31, 2025 | 4.95M | -86.66% |
| Dec 31, 2024 | 37.08M | -27.41% |
| Dec 29, 2023 | 51.09M | 406.54% |
| Dec 30, 2022 | 10.09M | -97.27% |
| Jul 26, 2022 | 368.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Purple Biotech | 6.45M |
| Silo Pharma | 6.40M |
| Liminatus Pharma | 6.38M |
| Evogene | 6.09M |
| Aptevo Therapeutics | 5.58M |
| FibroBiologics | 5.56M |
| Alaunos Therapeutics | 5.52M |
| BioAtla | 5.52M |